Cardiac involvement in patients with Autosomal Dominant Polycystic Kidney Disease and normal renal function after six years of follow-up
By:
References
- Abbasi F., Reaven G.M.: Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism, 2002; 51: 235–237
- Bardají A., Vea A.M., Gutierrez C., Ridao C., Richart C., Oliver J.A.: Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 1998; 32: 970–975
- Chapman A.B., Johnson A.M., Rainguet S., Hossack K., Gabow P., Schrier R.W.: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1997; 8: 1292–1297
- Chen H., Watnick T., Hong S.N., Daly B., Li Y., Seliger S.L.: Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients. BMC Nephrol., 2019; 20: 386
- de Almeida E.A., de Oliveira E.I., Lopes J.A., Almeida A.G., Lopes M.G., Prata M.M.: Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease. Rev. Port. Cardiol., 2007; 26: 235–243
- Ecder T.: Cardiovascular complications in autosomal dominant polycystic kidney disease. Curr. Hypertens. Rev., 2013; 9: 2–11
- Ecder T., Edelstein C.L., Chapman A.B., Johnson A.M., Tison L., Gill E.A., Brosnahan G.M., Schrier R.W.: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hyper-tensive patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 1999; 14: 1113–1116
- Ecder T., Schrier R.W.: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. J. Am. Soc. Nephrol., 2001; 12: 194–200
- Ecder T., Schrier R.W.: Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol., 2009; 5: 221–228
- Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G.: Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature, 2000; 408: 990–994
- Idrizi A., Barbullushi M., Strakosha A., Kodra S., Thereska N., Zaimi E., Gjyzari A., Petrela E.: The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease. G. Ital. Nefrol., 2007; 24: 595–599
- Ivy D.D., Shaffer E.M., Johnson A.M., Kimberling W.J., Dobin A., Gabow P.A.: Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1995; 5: 2032–2036
- Joly D., Hummel A., Ruello A., Knebelmann B.: Ciliary function of polycystins: A new model for cystogenesis. Nephrol. Dial. Transplant., 2003; 18: 1689–1692
- Kimberling W.J., Kumar S, Gabow P.A., Kenyon J.B., Connolly C.J., Somlo S.: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23. Genomics, 1993; 18: 467–472
- Lai S., Mastroluca D., Matino S., Panebianco V., Vitarelli A., Capotosto L., Turinese I., Marinelli P., Rossetti M., Galani A., Baiocchi P., D’Angelo A.R., Palange P.: Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease. Kidney Blood Press. Res., 2017; 42: 1290–1302
- Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F. 3rd, Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 2009; 150: 604–612
- Levy J.C., Matthews D.R., Hermans M.P.: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 1998; 21: 2191–2192
- Lumiaho A., Pihlajamäki J., Hartikainen J., Ikäheimo R., Miettinen R., Niemitukia L., Lampainen E., Laakso M.: Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am. J. Kidney Dis., 2003; 41: 1219–1224
- Mao Z., Xie G., Ong A.C.: Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 2015; 30: 197–203
- Martinez-Vea A., Valero F.A., Bardaji A., Gutierrez C., Broch M., Garcia C., Richart C., Oliver J.A.: Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors. Am. J. Nephrol., 2000; 20: 193–200
- Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z., Harris P.C., Torres V.E., Ehrlich B.E.: Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J. Mol. Cell. Cardiol., 2013; 58: 199–208
- Perrone R.D., Abebe K.Z., Schrier R.W., Chapman A.B., Torres V.E., Bost J., Kaya D., Miskulin D.C., Steinman T.I., Braun W., Winklhofer F.T., Hogan M.C., Rahbari-Oskoui F., Kelleher C., Masoumi A., et al.: Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol., 2011; 6: 2508–2515
- Pietrzak-Nowacka M., Safranow K., Bober J., Olszewska M., Birkenfeld B., Nowosiad M., Ciechanowski K.: Calcium-phosphate metabolism parameters and erythrocyte Ca2+ concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch. Med. Sci., 2013; 9: 837–842
- Pietrzak-Nowacka M., Safranow K., Czechowska M., Dutkiewicz G., Kornacewicz-Jach Z., Ciechanowski K.: Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner. Kidney Blood Press. Res., 2012; 36: 301–309
- Ravine D., Gibson R.N., Walker R.G., Sheffield L.J., Kincaid–Smith P., Danks D.M.: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet, 1994; 343: 824–827
- Rostoff P., Gackowski A., Nessler J., Piwowarska W.: Left ventricular hypertrophy – current views on the pathophysiology, association with cardiovascular risk, and therapeutic options. Kardiol. Pol., 2010; 68: 815–823
- The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell, 1994; 77: 881–894
- Timio M., Monarca C., Pede S., Gentili S., Verdura C., Lolli S.: The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred. Clin. Nephrol., 1992; 37: 245–251
- Valero F.A., Martinez-Vea A., Bardají A., Gutierrez C., Garcia C., Richart C., Oliver J.A.: Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1999; 10: 1020–1026
- Zeier M., Geberth S., Schmidt K.G., Mandelbaum A., Ritz E.: Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1993; 3: 1451–1457
DOI: https://doi.org/10.5604/01.3001.0015.0108 | Journal eISSN: 1732-2693
Language: English
Page range: 502 - 510
Submitted on: May 28, 2020
Accepted on: Feb 26, 2021
Published on: Jul 1, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2021 Maria Pietrzak-Nowacka, Krzysztof Safranow, Małgorzata Czechowska, Grażyna Dutkiewicz, Ewa Gątarska, Kazimierz Ciechanowski, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.